Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2014
12/02/2014US8901130 Low hygroscopic aripiprazole drug substance and processes for the preparation
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8900614 Intra-oral device for treating obesity
12/02/2014US8900552 Treatment of glycogen storage disease type II
11/2014
11/27/2014US20140349391 Method of collecting placental stem cells
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8895505 Method of treatment of type 2 diabetes
11/25/2014US8895498 GIP and exendin hybrid polypeptides
11/20/2014US20140343025 Pharmaceutical composition
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140342002 Particulate materials
11/18/2014US8889730 Indole and indazole compounds that activate AMPK
11/18/2014US8889715 Substituted pyridoxine-lactam carboxylate salts
11/18/2014US8889672 Compounds, formulations, and methods of protein kinase C inhibition
11/18/2014US8889658 Phosphonate compounds
11/18/2014US8889654 Food formulation comprising glycogen
11/18/2014US8889622 Methods of inhibiting seizure in a subject
11/18/2014US8889619 Fusion protein of Exendin-4 and its analog, preparation method and use thereof
11/18/2014US8889618 C-terminal fragments of glucagon-like peptide-1 (GLP-1)
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/18/2014US8889133 Methods of treating diabetes with Dll4 antagonists
11/18/2014US8889099 Methods and compositions for delivering peptides
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8883750 Method of treating diabetes
11/11/2014US8883723 Conjugate of insulin and vitamin B12 for oral delivery
11/11/2014US8883715 Biocompatible polymers, process for their preparation and compositions containing them
11/11/2014US8883504 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line
11/11/2014US8882075 Furnace mount
11/04/2014US8877890 Melanocortin-1 receptor-specific cyclic peptides
11/04/2014US8877750 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/04/2014US8877715 Cytotoxic conjugates having neuropeptide Y receptor binding compound
11/04/2014US8877708 Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders
11/04/2014US8877224 Compositions for preventing cardiac arrhythmia
11/04/2014US8877214 Pharmaceutical composition for modified release
10/2014
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871775 Compounds
10/28/2014US8871764 Lisofylline analogs and methods for use
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/16/2014US20140309236 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859729 Growth hormone releasing peptides
10/14/2014US8859617 Use of furan alkyl for preparing an antidiabetic drug
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014165566A1 Hydrophilic particle compositions, processes of production, and uses in dietary management and digestive disorders
10/09/2014WO2014165137A1 Compounds and methods for treating obesity and controlling weight
10/09/2014WO2014164756A1 Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
10/09/2014WO2014164404A1 2-aaa as a biomarker and therapeutic agent for diabetes
10/09/2014WO2014164286A1 Dual sglt1/sglt2 inhibitors
10/09/2014WO2014163262A1 Composition for treating or preventing obesity, containing chili seed extract
10/09/2014WO2014161919A1 Therapeutic uses of empagliflozin
10/09/2014WO2014161918A1 Therapeutic uses of empagliflozin
10/09/2014WO2014161837A1 Treatment of diabetes mellitus by long–acting formulations of insulins
10/09/2014WO2014161836A1 Treatment of metabolic disorders in equine animals
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140303077 Albumin fusion proteins
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/08/2014EP2786998A1 Thienyl [3, 2-d]pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof
10/08/2014EP2786985A2 Antagonists of the glucagon receptor
10/08/2014EP2785838A2 Targeted lysosomal enzyme compounds
10/08/2014EP2785837A2 Targeted enzyme compounds and uses thereof
10/08/2014EP2785702A1 Crystalline dapagliflozin hydrate
10/08/2014EP2785693A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
10/08/2014EP2785690A1 Piperidine derivatives, pharmaceutical compositions and uses thereof
10/08/2014EP2785366A1 Insulin glargine versus metformin for the first-line treatment of early type 2 diabetes
10/07/2014US8853212 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
10/07/2014US8853208 Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
10/07/2014US8853170 Compositions comprising sugar-cysteine products
10/07/2014US8853160 GLP-1, exendin-4, peptide analogs and uses thereof
10/07/2014US8853157 Methods of treating steroid-induced obesity using GLP-1 agonists
10/07/2014US8853156 Treatment for diabetes in patients inappropriate for metformin therapy
10/07/2014US8853155 Insulin derivatives containing additional disulfide bonds
10/07/2014US8853154 Fibronectin based scaffold domain proteins that bind to myostatin
10/07/2014US8853153 Agent for suppressing elevation of blood GIP concentration
10/07/2014US8853148 Compositions for masking the flavor of nutrients and methods for making same
10/02/2014WO2014160811A1 Compositions and methods for treating neuropathy
10/02/2014WO2014160476A1 Prebiotic composition and method of its use
10/02/2014WO2014159657A1 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
10/02/2014WO2014159054A1 Gpr120 agonists for the treatment of type ii diabetes
10/02/2014WO2014158033A1 Stabilized vitamin d formulations
10/02/2014WO2014157994A1 Novel oxazolidinone derivative as cetp inhibitor, its preparation method, and pharmaceutical composition comprising the same
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157607A1 Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014156505A1 Jelly-like tablet and jelly-like lozenge using same
10/02/2014WO2014156462A1 Agent for inducing differentiation of white adipocytes into brown-like adipocytes
10/02/2014WO2014156196A1 Therapeutic agent for type 2 diabetes
10/02/2014WO2014154099A1 Use of vegetable soybean in preparation of drugs for preventing and treating diabetes
10/02/2014WO2014154019A1 Long-lasting immune fusion protein for treating diabetes
10/01/2014EP2784074A1 Pyrazole compound and use thereof for medical purposes
10/01/2014EP2783698A1 Agents and methods for modulating macrophage inhibitory cytokine (MIC-1) activity
10/01/2014EP2783684A1 Prenylflavanone compounds for modulating diabetes
10/01/2014EP2782903A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
10/01/2014EP2782586A1 Improved synergistic anti-diabetic compositions
10/01/2014EP2782568A1 Tetrahydrocannabivarin (thcv) for use in the protection of pancreatic islet cells
09/2014
09/30/2014US8846906 5HT2C receptor modulators
09/30/2014US8846755 Sulfonamides for the prevention of diabetes
09/30/2014US8846696 Purine derivatives
09/30/2014US8846618 Stable formulation of modified GLP-1
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 1298